Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)
Titel:
Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)
Auteur:
Takeuchi, K. Togashi, Y. Kamihara, Y. Fukuyama, T. Yoshioka, H. Inoue, A. Katsuki, H. Kiura, K. Nakagawa, K. Seto, T. Maemondo, M. Hida, T. Harada, M. Ohe, Y. Nogami, N. Yamamoto, N. Nishio, M. Tamura, T.